Japanese Encephalitis Vaccine (JEV)
Closed Pre-Solicitation Posted
- Solicitation number
- SPE2DP-26-R-0001
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Philadelphia, Pennsylvania 19111, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical intends to solicit Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe under a sole-source procurement (FAR 6.302-1) with solicitation release expected by May 28, 2026. This is an unclassified, unrestricted procurement with no set-aside.
The successful contractor must hold FDA approval to sell JEV prior to the solicitation's closing date. The product shall be Vero cell culture derived, sterile, supplied as 0.5 ml sterile suspension in Type 1 glass prefilled syringes with chlorobutyl elastomer plunger stoppers, and manufactured in accordance with MPID Number 5 dated July 23, 2024. The vaccine must be approved for active immunization against Japanese Encephalitis in persons 2 months of age and older, with dosing of 0.25 ml for children ages 2 months to under 3 years and 0.5 ml for individuals 3 years and older. Expiration dating must be 24 months with a minimum of 21 months remaining at delivery. All shipments require constant refrigeration at 2–8°C with no temperature excursions, protection from freezing and light, and DLA-compatible temperature monitors. Packaging and marking must comply with ASTM D 3951, perishable material handling standards, and Medical Marking Standard No. 1D dated February 23, 2024.
The contract will be firm-fixed price, indefinite delivery and indefinite quantity with an 18-month base term. Minimum quantity is 277,760 units; estimated quantity is 277,760 units; maximum quantity is 394,240 units. Production lead time is 120 days after delivery order issuance. Delivery is FOB Destination to DLA Distribution Susquehanna, New Cumberland, Pennsylvania 17070, Attn: Jim Earp (DODAAC SV3100). The government will procure under FAR Part 12 (Commercial Items). All responsible sources may submit a proposal.
Notice text
2 versions
Update #2 · Latest ·
Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) - Synopsis
Solicitation: SPE2DP-26-R-0001
Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)
NSN: 6505-01-607-7018
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 5 dated 23 July 2024, which is attached to this notice.
The Solicitation will be issued under authority 10 U.S.C. § 3204(a)(1), implemented by FAR 6.302-1 (“Only one responsible source and no other supplies or services will satisfy agency requirements”).
The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of an eighteen (18) month base term. The minimum quantity is 277,760 each (EA). The estimated quantity is 277,760 each. The maximum quantity is 394,240 each.
Inspection/Acceptance at Destination
FOB Destination
Delivery Destination:
DODAAC: SV3100
DLA Distribution Susquehanna
U Avenue, Bldg. 89, Door 6
New Cumberland, PA 17070
Attn: Jim Earp
Production Lead Time is 120 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell JEV prior to the Solicitation’s closing date and time.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-26-R-0001 is expected to be issued on or around August 2026.
******************************************************************************
Contracting Office Address:
Defense Logistics Agency, Acquisition Management, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA, 19111-5092, UNITED STATES
Point of Contact:
Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil
Update #1 ·
Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV) - Synopsis
Solicitation: SPE2DP-26-R-0001
Item: Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV)
NSN: 6505-01-607-7018
Description:
The Defense Logistics Agency Troop Support has a requirement for the supply of Japanese Encephalitis Virus Vaccine, Purified, Inactivated, Single-Dose Prefilled Syringe (JEV). JEV shall be made in accordance with MPID Number 5 dated 23 July 2024, which is attached to this notice.
The Solicitation will be issued under authority 10 U.S.C. § 3204(a)(1), implemented by FAR 6.302-1 (“Only one responsible source and no other supplies or services will satisfy agency requirements”).
The Government intends to use Part 12 for this acquisition – per FAR 10.002(d)(2).
The proposed contract will be a firm-fixed price, indefinite delivery, indefinite quantity type contract. The contract will consist of an eighteen (18) month base term. The minimum quantity is 277,760 each (EA). The estimated quantity is 277,760 each. The maximum quantity is 394,240 each.
Inspection/Acceptance at Destination
FOB Destination
Delivery Destination:
DODAAC: SV3100
DLA Distribution Susquehanna
U Avenue, Bldg. 89, Door 6
New Cumberland, PA 17070
Attn: Jim Earp
Production Lead Time is 120 days after issuance date of the delivery order (DD1155).
All responsible sources may submit a proposal and shall be considered by the Agency.
The successful contractor shall have FDA approval to sell JEV prior to the Solicitation’s closing date and time.
****************************************************************************
IMPORTANT NOTICES
Availability of solicitations, FAR 5.102(d) applies, as our office no longer issues solicitations or amendments in paper form. Offeror should register to receive notification of this solicitation or solicitation amendments. The solicitation will be posted on the DLA Internet Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil/. Detailed system requirements and instructions for registration can be found on the DLA DIBBS Home Page accessed on https://www.dibbs.bsm.dla.mil/. Once the solicitation is posted, it will be available for viewing on DIBBS. From the DIBBS homepage, select "Solicitations" from the top bar to search for the solicitation. DIBBS Help can be accessed from the DIBBS homepage. Interested parties are further advised to set up automated notifications of solicitation changes through this website. Solicitation SPE2DP-23-R-0002 is expected to be issued on or around May 2024.
******************************************************************************
Contracting Office Address:
Defense Logistics Agency, Acquisition Management, DLA Troop Support - Medical, 700 Robbins Avenue, Philadelphia, PA, 19111-5092, UNITED STATES
Point of Contact(s):
Alec Deichman, Contracting Specialist, Phone: 445-737-5743 , Email: Alec.Deichman@dla.mil
Jessica De La Hoz, Contracting Officer, Phone: 445-737-3623, Email: Jessica.DeLaHoz@dla.mil
Files
| File | Type | Posted |
|---|---|---|
| JEV_MPID 5_23Jul2024.pdf | ||
| MMS No.1D.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Pre-Solicitation | |
| Japanese Encephalitis Vaccine (JEV) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity